The need for radiopharmaceuticals is growing steadily with the increased clinical utilization of molecular imaging. Siemens provides the biomarkers by which the biology of disease can be characterized in individual patients and helps to drive the development and use of more effective personalized treatments. Eclipse Cyclotrons, Explora Chemistry Modules and the PETNET distribution network make up Siemens' comprehensive solutions portfolio in PET biomarker manufacture and distribution.